Trial intelligence / Profile preview

Phase 2 study of carfilzomib + elotuzumab + dexamethasone for relapsed or progressed multiple myeloma

2016-001178-13Phase 2Completed

Sponsor

Helsinki University Hospital

Start

Dec 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1